Page 92 - Simons Foundation News Today

/PRNewswire/ -- Chemical Marketing & Economics, Inc. (CME) and Air Products (NYSE: APD) today announced that Seifi Ghasemi, chairman, president and chief...

Drugmakers have been using genetically modified cells as small drug factories for over 40 years. These cells can be instructed to produce chemicals that can be utilized to treat cancer and autoimmune diseases like arthritis.

The immune system protects us from a full spectrum of pathogens, but without balance, it can end up hurting us over time, too. The immunologist Shruti Naik explains how our defenses can turn on us.

The advance could have implications for drug development and biological research.

New research digs into what's happening in the brain to keep your eyes focused on something you're reaching for, like a ground ball or grocery store item.

For nearly 40 years, drugmakers have used genetically engineered cells as tiny drug factories. Such cells can be programmed to secrete compounds that yield drugs used to treat cancer and autoimmune conditions such as arthritis.

KU associate professor of mathematics receives award from National Science Foundation

Secrets of the Surface:The Mathematical Vision Of Maryam MirzakhaniA documentary film by George Csicery Secrets of the Surface introduces Maryam Mirzakhani to a wider public, telling th

The amygdala, an area of the brain critical for interpreting emotions, grows too rapidly in babies who go on to develop autism.

/PRNewswire/ -- When mice with atopic dermatitis—a common type of allergic skin inflammation—are treated with drugs that target the immune system, their...